Medical Research News

RSS

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

Key blood marker can lead to effective melanoma treatments

An Edith Cowan University (ECU) study has revealed that a key blood marker of cancer could be used to select the most effective treatment for melanoma.

16 Oct 2020

Study: COVID-19 has prompted Americans to focus more on their health

A new study released today by digital health company Rally Health, Inc. found a significant proportion of Americans have a poor understanding of preventive care, while at the same time, COVID-19 has prompted them to focus more on their health.

16 Oct 2020

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

In just six months, the world's largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19.

16 Oct 2020

Gene variants may provide clues to successful treatment of pediatric eosinophilic esophagitis

A group of three gene variants, commonly inherited together, may provide clues to more successful treatment of pediatric eosinophilic esophagitis (EoE), a chronic inflammation of the food pipe often confused with gastroesophageal reflux disease (GERD).

16 Oct 2020

Study explores low back pain and its impact on athletes’ experience

Trinity College Dublin researchers have carried out the first multi-centred, international, qualitative study exploring the athlete experience (in their own words) of sporting low back pain (LBP).

16 Oct 2020

New article explores the endemic potential of COVID-19 virus

A new article by Columbia Mailman School researchers Jeffrey Shaman and Marta Galanti explores the potential for the COVID-19 virus to become endemic, a regular feature producing recurring outbreaks in humans.

16 Oct 2020

Novel method can predict influenza epidemics

Researchers at Linköping University, Sweden, have developed a unique method to predict influenza epidemics by combining several sources of data.

16 Oct 2020

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.

16 Oct 2020

A better understanding of the gut-brain axis may lead to new treatments for neurological disorders

Anyone who has experienced "butterflies in the stomach" before giving a big presentation will be unsurprised to learn there is a physical connection between their gut and their brain.

16 Oct 2020

Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment, had a "rapid and complete response" to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center and the Georgetown Lombardi Comprehensive Cancer Center, both of whom are part of the Georgetown Lombardi Comprehensive Cancer Center Consortium.

16 Oct 2020

Impact of COVID-19 on Australians with hypertension

Ten months into the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is unclear how people with hypertension are coping, given their increased risk. A retrospective case-control study compared people with hypertension to matched healthy controls during COVID-19 lockdown to determine whether they have higher risk perceptions, anxiety, and prevention intentions. The study is published on the preprint server medRxiv* in October 2020.

16 Oct 2020

Scientists discover a novel antiviral strategy for treating COVID-19

A research team led by Professor Hongzhe SUN, Norman & Cecilia Yip Professor in Bioinorganic Chemistry, Department of Chemistry, Faculty of Science, and Professor Kwok Yung YUEN, Henry Fok Professor in Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKU), has discovered a novel antiviral strategy for treatment of COVID-19.

16 Oct 2020

Study: Combining sound and electrical stimulation of tongue can reduce tinnitus

In the largest clinical trial of its kind, researchers show that combining sound and electrical stimulation of the tongue can significantly reduce tinnitus, commonly described as "ringing in the ears." They also found that therapeutic effects can be sustained for up to 12 months post-treatment.

16 Oct 2020

REFLECT II clinical trial evaluates safety and efficacy of cerebral embolic deflection filter

The REFLECT II randomized clinical trial evaluating the safety and efficacy of a device designed to reduce cerebral embolization and ischemic stroke, complications of transcatheter aortic valve replacement (TAVR), found that the device met the primary safety endpoint compared to historical controls but did not demonstrate superiority of the device for the primary hierarchical efficacy endpoint.

16 Oct 2020

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Now, a recent study published on the preprint server bioRxiv in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs, and their functional attributes.

16 Oct 2020

Researchers examine the 'social brain' responsible for interacting with other people

A team of Russian researchers with the participation of a leading researcher at HSE University, Ekaterina Pechenkova, found that during group problem solving the components of the social brain are co-activated, but they do not increase their coupling during cooperation as would be suggested for a holistic network.

16 Oct 2020

Medical Research News

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

Key blood marker can lead to effective melanoma treatments

Study: COVID-19 has prompted Americans to focus more on their health

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

Gene variants may provide clues to successful treatment of pediatric eosinophilic esophagitis

Study explores low back pain and its impact on athletes’ experience

New article explores the endemic potential of COVID-19 virus

Novel method can predict influenza epidemics

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

A better understanding of the gut-brain axis may lead to new treatments for neurological disorders

Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

Impact of COVID-19 on Australians with hypertension

Scientists discover a novel antiviral strategy for treating COVID-19

Study: Combining sound and electrical stimulation of tongue can reduce tinnitus

REFLECT II clinical trial evaluates safety and efficacy of cerebral embolic deflection filter

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Researchers examine the 'social brain' responsible for interacting with other people

Scientists develop a conceptual model to identify health impacts of autonomous vehicles

Study challenges current standard for managing blood pressure in people with spinal cord injury

Exposure to ancient parasites may be linked to humans’ response to coronavirus

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News